UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Kolon unveils trial results for Invossa at cartilage repair conference
Kolon Life Science said Friday that it has presented its local phase 3 clin...
by Lee Han-soo
|
2018-04-20 15:57
라인
Blockbuster Remicade losing out to Korean biosimilars in US
Biosimilar drugs developed by Korean pharmaceutical firms are gradually car...
by So Jae-hyeon
|
2018-04-19 15:39
라인
Hanmi gets FDA nod for nonalcoholic steatohepatitis treatment trials
Hanmi Pharmaceutical said Thursday that it has received approval to go ahea...
by Lee Han-soo
|
2018-04-19 15:29
라인
Biotech stocks could be overpriced: analysts
Analysts are warning investors that biotech shares could be overpriced, as ...
by Nam Doo-hyun
|
2018-04-19 13:34
라인
Pharmbio to market Shionogi’s dyspareunia treatment
Shionogi Inc. President and CEO John Keller (left) and Pharmbio Korea CEO N...
by Lee Han-soo
|
2018-04-18 14:10
라인
ViroMed confirms VM202’s pain control in animal test
ViroMed said it has confirmed that VM202, an investigational gene therapy b...
by Nam Doo-hyun
|
2018-04-18 11:39
라인
‘Genexine’s pipelines worth more than ₩3 trillion’
Biotech firm Genexine’s major pipelines could be worth more than 3 trillion...
by Nam Doo-hyun
|
2018-04-16 15:48
라인
Daewoong opens biotech research lab in Indonesia
Daewoong Pharmaceutical said it has established a biotech research center a...
by So Jae-hyeon
|
2018-04-12 11:37
라인
Biotech CEOs roll up sleeves for global biz
CEOs of Korea’s major biotech companies are directly involving in marketing...
by So Jae-hyeon
|
2018-04-10 12:09
라인
Samsung Bioepis settles patent disputes with AbbVie on Humira
Samsung Bioepis said Thursday that it has settled a patent dispute with Abb...
by Lee Han-soo
|
2018-04-06 15:21
라인
CTC Bio gets sales nod for erectile dysfunction treatment in Vietnam
CTC Bio said Tuesday that it has acquired marketing approval for its erecti...
by Lee Han-soo
|
2018-04-04 10:59
라인
Steelmaker POSCO to challenge biotech sector
Korea’s largest steelmaker POSCO is entering the pharmaceutical market.Kwon...
by So Jae-hyeon
|
2018-04-03 11:58
라인
Toolgen to develop hepatitis B treatment
Toolgen said Friday that it would develop a chronic hepatitis B treatment u...
by Lee Han-soo
|
2018-03-30 17:28
라인
Kangstem Biotech wins patent on neural stem cells
Kangstem Biotech said Thursday that it has acquired a patent regarding the ...
by Lee Han-soo
|
2018-03-29 17:12
라인
Huons wins sales approval for hyaluronic acid filler in Indonesia
Elravie Huons, a subsidiary of Huons Global, said Thursday that it has re...
by Lee Han-soo
|
2018-03-29 15:10
라인
Stem cell therapy developers unaffected by Cha Biotech debacle
Shares of biotech firms specializing in stem cell therapies are performing ...
by Nam Doo-hyun
|
2018-03-26 15:58
라인
KRX names CHA Biotech as administrative issue, leading to 30% stock fall
CHA Biotech, one of the promising bio-stocks, has been downgraded to an adm...
by Marian Chu, Lee Han-soo
|
2018-03-23 15:16
라인
Foreigners buy SillaJen, Samsung BioLogics, dump Celltrion
Foreign investors net purchased shares of SillaJen and Samsung BioLogics, a...
by Nam Doo-hyun
|
2018-03-20 12:01
라인
LG Chem gets approval for Enbrel biosimilar
LG Chem has received sales approval from the Ministry of Food and Drug Safe...
by Lee Han-soo
|
2018-03-19 12:14
라인
Jointstem fails to win conditional nod
Jointstem, a stem cell therapy for degenerative arthritis, failed to obtain...
by Lee Hye-seon
|
2018-03-19 12:12
-
이전
21
22
23
24
25
26
27
28
29
30
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top